loadpatents
name:-0.0043659210205078
name:-0.017102956771851
name:-0.00041007995605469
Arison, Byron H Patent Filings

Arison, Byron H

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arison, Byron H.The latest application filed is for "alpha v integrin receptor antagonists".

Company Profile
0.17.2
  • Arison, Byron H - Watchung NJ
  • Arison; Byron H. - Watchung NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Alpha v integrin receptor antagonists
App 20040254211 - Arison, Byron H ;   et al.
2004-12-16
.alpha. v integrin receptor antagonists
Grant 6,426,353 - Arison , et al. July 30, 2
2002-07-30
Alpha v integrin receptor antagonists
App 20020049224 - Arison, Byron H. ;   et al.
2002-04-25
Quinoline leukotriene antagonists
Grant 5,952,347 - Arison , et al. September 14, 1
1999-09-14
Microbial transformation product having immunosuppressive activity
Grant 5,352,783 - Shafiee , et al. October 4, 1
1994-10-04
Process for producing immunosuppressant agent
Grant 5,324,644 - Ruby , et al. June 28, 1
1994-06-28
Biotransformation process for the production of invermectin derivatives
Grant 5,250,422 - Petuch , et al. October 5, 1
1993-10-05
Cyclcic FR-900520 microbial biotransformation agent
Grant 5,221,625 - Chen , et al. June 22, 1
1993-06-22
Biological process for producing 17.beta.-N-monosubstituted carbamoyl-11-oxo-4-aza-5-.alpha.-androst-3-one testosterone-5-.alpha. reductase inhibitors
Grant 5,215,894 - Arison , et al. June 1, 1
1993-06-01
Process for selectively acylating immunomycin
Grant 5,210,030 - Petuch , et al. May 11, 1
1993-05-11
Synthesis of protease inhibitor
Grant 5,192,668 - Treiber , et al. March 9, 1
1993-03-09
C-31 methylated FR-900520 cyclic hemiketal immunosuppressant agents
Grant 5,149,701 - Shafiee , et al. September 22, 1
1992-09-22
Immunoregulants, immunosuppressants, process to make ring expanded macrolide related to FK-506/FK-520
Grant 5,057,608 - Wyvratt, Jr. , et al. October 15, 1
1991-10-15
Process for preparation of novel angiotensin II antagonists
Grant 5,053,329 - Chen , et al. October 1, 1
1991-10-01
Microbial transformation process for preparing anti-hypertensive products
Grant 5,049,565 - Chen , et al. September 17, 1
1991-09-17
FK-520 microbial transformation product
Grant 4,987,139 - Chen , et al. January 22, 1
1991-01-22
Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs
Grant 4,965,200 - Chen , et al. October 23, 1
1990-10-23
HMG-CoA reductase inhibitors
Grant 4,738,982 - Arison , et al. April 19, 1
1988-04-19
Novel derivatives of C-076 compounds
Grant 4,285,963 - Arison , et al. August 25, 1
1981-08-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed